Form 4: Sight Sciences Director Catherine Mazzacco Receives Stock Grant

Sentiment:

SEC Form 4 Filing


Director Catherine Mazzacco acquired 17,366 restricted stock units in Sight Sciences, Inc. on June 6, 2024.

Summary

  • Catherine Mazzacco, a director of Sight Sciences, Inc., reported a transaction on June 6, 2024.
  • She acquired 17,366 restricted stock units (RSUs) under the Issuer's Non-Employee Director Compensation Program.
  • These RSUs represent a contingent right to receive one share of Sight Sciences' common stock each.
  • The number of RSUs granted is calculated as $120,000 divided by the closing price of the common stock on the grant date.
  • The RSUs vest on the earlier of June 6, 2025, or the date of the Issuer's 2025 annual meeting of stockholders, contingent upon continued service as a director.
  • Following the transaction, Mazzacco beneficially owns 47,555 securities, including common stock and RSUs.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, indicating stability and alignment of interests. It's a neutral-positive event.

Positives

  • The grant of RSUs to a director aligns their interests with those of the shareholders.
  • The vesting schedule incentivizes continued service and commitment to the company.

Future Outlook

The document does not contain specific forward-looking statements, but the vesting of RSUs in 2025 suggests an expectation of continued service by the director.

Industry Context

Grants of stock and options to directors are a common practice in publicly traded companies to align the interests of directors with those of shareholders. The size and vesting schedule of the grant are typical for director compensation.

Comparison to Industry Standards

  • Director compensation packages often include a mix of cash and equity.
  • Equity grants, such as RSUs, are typically valued based on a percentage of the director's annual retainer or a fixed dollar amount.
  • Vesting schedules are usually tied to continued service on the board, often over a oneto three-year period.
  • Companies like Alcon and Johnson & Johnson also use similar compensation methods for their board members.

Stakeholder Impact

  • Shareholders: The RSU grant aligns the director's interests with those of the shareholders, incentivizing value creation.
  • Employees: The grant reflects a commitment to retaining key personnel, which can boost employee morale.

Key Dates

DateDescription
06/08/2023Date of previous RSU grant to the Reporting Person.
06/06/2024Date of the transaction: grant of 17,366 restricted stock units.
06/06/2025Vesting date of the RSUs, or the date of the Issuer's 2025 annual meeting of stockholders, whichever is earlier.
06/10/2024Date of the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.